Țară: Israel
Limbă: engleză
Sursă: Ministry of Health
HUMAN-RABIES IMMUNOGLOBULIN
CSL BEHRING LTD., ISRAEL
J06BB05
SOLUTION FOR INJECTION
HUMAN-RABIES IMMUNOGLOBULIN 150 IU/ML
I.M
Required
CSL BEHRING GmbH, GERMANY
RABIES IMMUNOGLOBULIN
RABIES IMMUNOGLOBULIN
Prophylaxis of rabies.
2014-05-31
ע עבקנ הז ןולע טמרופ " לע רשואו קדבנ ונכותו תואירבה דרשמ י - ודי PACKAGE INSERT READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE. - Keep this leaflet. You may need to read it again. - If you have further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. - If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. BERIRAB Solution for injection for intramuscular use ACTIVE INGREDIENT: Human rabies immunoglobulin. PHARMACOTHERAPEUTIC GROUP Immune sera and immunoglobulins, human rabies immunoglobulin ATC-code: J06B B05 THERAPEUTIC INDICATIONS Post-exposure prophylaxis of rabies infection after ● exposure to scratches, bites or other injuries caused by a suspected rabid animal ● mucous membrane contamination with infectious tissue or saliva of a suspected rabid animal ● contact of mucous membranes or newly skin injury with rabies live attenuated vaccine e.g. vaccination baits. Human rabies immunoglobulin must always be used in combination with a rabies vaccine. National and/or WHO guidelines regarding protection against rabies should be observed. CONTRAINDICATIONS Because of the life-threatening risk due to rabies, there are no contraindications to the administration of rabies immunoglobulin. SPECIAL WARNINGS AND PRECAUTIONS FOR USE Ensure that Berirab is not administered into a blood vessel because of the risk of shock. True hypersensitivity reactions are rare. Berirab contains a small quantity of IgA. Individuals who are deficient in IgA have the potential for developing IgA antibodies and may have anaphylactic reactions after administration of blood components containing IgA. Rarely human rabies immunoglobulin can induce a fall in blood pressure with anaphylactic reactions, even in patients who had tolerated previous treatment w Citiți documentul complet